Anastomotic dehiscence during treatment with bevacizumab 5 years after colo-anal anastomosis with proposition for management without stopping chemotherapy

Clin Res Hepatol Gastroenterol. 2011 Sep;35(8-9):594-6. doi: 10.1016/j.clinre.2011.04.011. Epub 2011 Aug 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / surgery*
  • Aged
  • Anal Canal / surgery*
  • Anastomosis, Surgical
  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Bevacizumab
  • Colon / surgery*
  • Combined Modality Therapy
  • Humans
  • Male
  • Rectal Neoplasms / drug therapy
  • Rectal Neoplasms / surgery*
  • Surgical Wound Dehiscence / chemically induced*
  • Time Factors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab